Search | IOVS | ARVO Journals

View

Showing 1 – 12 of 12

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract September 2016

Prevalence of drusen and conversion to neovascular age-related macular degeneration in the HARBOR study fellow eyes

Caroline R Baumal; Carlos Quezada Ruiz; Shamika Gune; Pin-wen Wang; Anne E Fung

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4967. doi:

ARVO Annual Meeting Abstract September 2016

Pan-retinal photocoagulation for diabetic retinopathy: is it one and done?

Victor H Gonzalez; Pin-wen Wang; Carlos Quezada Ruiz; Anne E Fung

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):6355. doi:

ARVO Annual Meeting Abstract June 2015

Durability of diabetic retinopathy improvement and impact of delayed therapy with ranibizumab (RBZ) during the RIDE/RISE open-label extension (OLE)

Jennifer K Sun; Pin-wen Wang; Anne E. Fung

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3143. doi:

ARVO Annual Meeting Abstract June 2015

Low luminance vision improves nearly twice as much as standard vision with ranibizumab for neovascular age-related macular degeneration

Ronald E P Frenkel; Anne E. Fung; Howard Shapiro; Ivaylo Stoilov

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5358. doi:

ARVO Annual Meeting Abstract June 2015

Impact of cataract surgery during treatment with ranibizumab in patients with diabetic macular edema (DME)

Andrew A Moshfeghi; Howard Shapiro; Anne E. Fung

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1747. doi:

ARVO Annual Meeting Abstract March 2012

Visual Acuity and Injection Frequency Results of 2mg Ranibizumab for Pigment Epithelial Detachments Refractory to Conventional Dosing in the HiPED study

Anne E. Fung; Brandon G. Busbee; John W. Kitchens; Jan Kristine Bayabo; Richard E. Shaw

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):4180. doi:

ARVO Annual Meeting Abstract March 2012

Effects Of Ranibizumab Injections On Functional Vision In Advanced Amd

Manfred MacKeben; Donald C. Fletcher; Anne E. Fung; Michael J. Jumper; Steve R. Sanislo

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):4395. doi:

ARVO Annual Meeting Abstract March 2012

Lucentis in Advanced MAcular degeneration (LAMA) Trial - Visual Function Questionnaire (VFQ) Results

Steven R. Sanislo; Anne E. Fung; Michael J. Jumper; Manfred MacKeben; Donald C. Fletcher

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):4396. doi:

ARVO Annual Meeting Abstract March 2012

Fluorescein Angiographic Response to 2mg Ranibizumab for AMD Pigment Epithelial Detachments Refractory to Conventional Dosing in the HiPED Study

Edward H. Wood; John W. Kitchens; Anne E. Fung; Brandon G. Busbee; Jan K. Bayabo; Richard E. Shaw

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):2040. doi:

ARVO Annual Meeting Abstract March 2012

OCT response to 2mg ranibizumab for AMD Pigment Epithelial Detachments refractory to conventional dosing in the HiPED study

Brandon G. Busbee; Anne E. Fung; John W. Kitchens; Brandon J. Lujan; Jan Kristine Bayabo; Richard E. Shaw

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):2041. doi:

ARVO Annual Meeting Abstract March 2012

Volumetric SDOCT Imaging of Pigment Epithelial Detachments in the HiPED Study

Jan Kristine T. Bayabo; Anne E. Fung; John W. Kitchens; Brandon G. Busbee; Brandon J. Lujan

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):818. doi:

ARVO Annual Meeting Abstract April 2011

Povidone-iodine Before Lidocaine Gel Anesthesia Achieves Surface Antisepsis

Rishi R. Doshi; Theodore Leng; Anne E. Fung

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):5826. doi:

Advertisement